Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance [...]
While the role that COVID-19 plays in the pathophysiology of PP is not established, this study offers preliminary evidence that provides us a stronger grasp of how certain viral infections, like coronavirus, can predispose to postpartum psychiatric illnesses.
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance [...]
The reality is that most of the antidepressants taken by women today are relatively safe and carry a very low risk to the developing fetus.Â
Because pregnant and postpartum women face unique challenges in the context of the COVID-19 pandemic, they may be at increased risk for mental health problems in this setting. In a recent study, researchers from the University College of London surveyed 162 new mothers in London between May and June 2020 using a social network survey designed to assess the impact of the COVID-19 lockdown.Â
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
While we have relatively limited information regarding the prevalence of obsessive-compulsive disorder (OC) during pregnancy and the postpartum period. Previous studies have indicated that women may be more vulnerable to the onset of OCD during [...]
A significant number of women consume cannabis while breastfeeding. What do we know about the effects of cannabis on the nursing infant?
Postpartum depression (PPD) is a relatively common problem, affecting between 10% and 15% of women after delivery. Although it is difficult to reliably predict which women in the general population will experience postpartum depression, it [...]
This international survey demonstrates that pregnant and postpartum women are more likely to report elevated symptoms of depression, anxiety, and post-traumatic stress than others in the general population in the context of the COVID-19 pandemic.
